Brent L. Saunders, Director at BridgeBio Pharma, Inc. (BBIO), bought 17,600 shares at $14.48 ($255K) on 2021-12-29, disclosed to the SEC on 2022-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SPRY | SELL | 2025-05-22 | $1.7M | — | Filing → |
| SKIN | BUY | 2024-08-13 | $44K | — | Filing → |
| BLCO | BUY | 2024-08-07 | $505K | — | Filing → |